Cancer gene therapy through autonomous parvovirus--mediated gene transfer

Current Gene Therapy
Jan CornelisJ Rommelaere

Abstract

Parvoviruses are small nuclear replicating DNA viruses. The rodent parvoviruses are usually weakly pathogenic in adult animals, bind to cell surface receptors which are fairly ubiquitously expressed on cells, and do not appear to integrate into host chromosomes during either lytic or persistent infection. The closely related rodent parvoviruses MVM, H-1 and LuIII efficiently infect human cell lines. Most interesting, malignant transformation of human and rodent cells was often found to correlate with a greater susceptibility to parvovirus-induced killing (oncolysis) and with an increase in the cellular capacity for amplifying and / or expressing the incoming parvoviral DNA. These and other interesting properties make these autonomous rodent parvoviruses and recombinant derivatives promising candidate antitumor vectors. Capsid replacement vectors have been produced from MVM or H-1 virus that carry transgenes encoding either therapeutic products (cytokines/chemokines, Apoptin, herpes simplex virus thymidine kinase) or marker proteins (green fluorescent protein, chloramphenicolacetyl transferase, luciferase). This review describes the current state of the art regarding the potential application of wild-type parvoviruses and derive...Continue Reading

Citations

Dec 13, 2006·Journal of Nanobiotechnology·Leona GilbertChristian Oker-Blom
Feb 9, 2010·Trends in Molecular Medicine·Stefan Grimm, Mathieu Noteborn
Oct 20, 2009·European Journal of Pharmacology·Mathieu H M Noteborn
Apr 28, 2009·Advanced Drug Delivery Reviews·Dominik E Dorer, Dirk M Nettelbeck
Mar 27, 2007·Cancer Letters·Markus J V Vähä-KoskelaAri E Hinkkanen
Jun 27, 2006·The Journal of Gene Medicine·Susanne I LangJan J Cornelis
Oct 27, 2009·International Journal of Cancer. Journal International Du Cancer·Sebastian DempeChristiane Dinsart
Dec 27, 2012·Journal of Proteomics·Pierre GarcinNelly Panté
Dec 17, 2014·Cytokine & Growth Factor Reviews·Katrien Van RaemdonckSofie Struyf
Sep 3, 2005·Cancer Gene Therapy·S E LawlerE A Chiocca
Jan 19, 2008·Cancer Gene Therapy·L KrügerJ A Kleinschmidt
Jan 25, 2007·Basic & Clinical Pharmacology & Toxicology·Sharon J OlijslagersMathieu H M Noteborn
Jun 21, 2019·Viruses·Clemens Bretscher, Antonio Marchini
Apr 28, 2011·Experimental Biology and Medicine·Konstantinos ArgirisMahvash Tavassoli
Jul 13, 2021·JCO Precision Oncology·Omeed MoavenMitesh J Borad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Artificial Chromosomes

Artificial chromosomes are genetically engineered chromosomes derived from the DNA of a species. Discover the latest research on artificial chromosomes here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
Assia L AngelovaZahari Raykov
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Assia L AngelovaZahari Raykov
© 2021 Meta ULC. All rights reserved